Skip to content
★ Sign in to follow
Suzhou Basecare Medical Corporation Ltd. - B - H Shares logo

Suzhou Basecare Medical Corporation Ltd. - B - H Shares Stock: price and insider trades · Hong Kong

HK·Mcap HK$351.3MHealth Care

1 insider bought €8,718 of shares over the last 90 days, the latest by liang bo, filed 28 Oct 2026.

Suzhou Basecare Medical Corporation Ltd. - B - H Shares: what insiders have been doing

This page follows insider dealings at Suzhou Basecare Medical Corporation Ltd. - B - H Shares as filed with HKEX, a company from the Health Care sector. 1 insider has disclosed 2 filings since 28 October 2025.

No insider sold shares on the market over the period. Instead, the filings list 2 purchases totalling €8,718, made by 1 insider. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 1 senior executive. The largest single trade was a purchase of €4,876 by Liang Bo, published on 16 October 2026.

For context, the typical company on the same exchange (median of 1,318 companies) published 4 filings over the same period, against 2 filings here. Looking back to 2026, when coverage begins, insiders filed 2 purchases and no sales.

The last insider purchase was made public on 28 October 2026, 11 days ago.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.

Insider Decl.
2
Thresholds
n/a
Buy Volume
€8,718
2 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Liang Bo2 buys

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 25,392 of 26,897 companies
16.3
score / 100
Value
3
Quality
29
FCF yld-71%
Earn yld-63%
EV/EBITDA·
ROE-18%
Gross mgn53%
Net mgn-96%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$1.29
Analyst consensus
1 analysts
·
HK$1.63Target HK$1.63(+27%)HK$1.63
Income statement
RevenueHK$233.3M
Gross profitHK$123.6M53% margin
EBITDA-HK$165.7M-71% margin
Net income-HK$223.5M-66.8% margin
Valuation
P/Book0.3x
Beta0.07
Balance sheet & cash
Market capHK$351.3M
Total debtHK$343.4M
Free Cash Flow-HK$253.4M
Debt / Equity40%
Profitability & ownership
ROE-18.4%
ROA-6.3%
% insiders0.0%
% institutions7.3%
Last declaration on 28 October 2026
Declarations2 total
  • ▲
    DirectorExecutives
    33,816 HKD0HKEX
    26,000 shares@ HK$1.3006ShareXHKGHKEX:DA20261027E00566
    Canonical exit: 24 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    42,900 HKD19HKEX
    33,000 shares@ HK$1.30100.0% of flowShareXHKGHKEX:DA20261015E00490
    Canonical exit: 12 Jan 2027 (T+90)

2 of 2 declarations

About Suzhou Basecare Medical Corporation Ltd. - B - H Shares

Suzhou Basecare Medical Corporation Ltd. is a company focused on the development and manufacturing of medical devices. It is listed under the B category of H shares.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations